Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope

por Chang, Tsung-Che, Manabe, Yoshiyuki, Ito, Keita, Yamamoto, Ryuku, Kabayama, Kazuya, Ohshima, Shino, Kametani, Yoshie, Fujimoto, Yukari, Lin, Chun-Cheng, Fukase, Koichi
Publicado 2022

Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with (89)Zr or (211)At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma

por Watabe, Tadashi, Kabayama, Kazuya, Naka, Sadahiro, Yamamoto, Ryuku, Kaneda, Kazuko, Serada, Satoshi, Ooe, Kazuhiro, Toyoshima, Atsushi, Wang, Yang, Haba, Hiromitsu, Kurimoto, Kenta, Kobayashi, Takanori, Shimosegawa, Eku, Tomiyama, Noriyuki, Fukase, Koichi, Naka, Tetsuji
Publicado 2023